A Randomized Exploratory Trial of an Alpha-7 Nicotinic Receptor Agonist (TC-5619) for Cognitive Enhancement in Schizophrenia

Alpha7 Neuronal Nicotinic Receptors as Targets for Novel Therapies to Treat Multiple Domains of Schizophrenia

(2011) Aaron J. Kucinski et al.   CURRENT PHARMACEUTICAL BIOTECHNOLOGY

Static and Dynamic Cognitive Deficits in Childhood Preceding Adult Schizophrenia: A 30-Year Study

(2010) Abraham Reichenberg et al.   AMERICAN JOURNAL OF PSYCHIATRY

α7 Nicotinic Receptor Agonists as Cognitive Treatments: Is Less (or Less Often) More?

(2010) Robert W. Buchanan et al.   BIOLOGICAL PSYCHIATRY

Immediate and Sustained Improvements in Working Memory After Selective Stimulation of α7 Nicotinic Acetylcholine Receptors

(2010) Stacy A. Castner et al.   BIOLOGICAL PSYCHIATRY

Effects of an Alpha 7-Nicotinic Agonist on Default Network Activity in Schizophrenia

(2010) Jason R. Tregellas et al.   BIOLOGICAL PSYCHIATRY

Nicotine and cotinine increases the brain penetration of saquinavir in rat

(2010) Vamshi K. Manda et al.   JOURNAL OF NEUROCHEMISTRY

TC-5619: An alpha7 neuronal nicotinic receptor-selective agonist that demonstrates efficacy in animal models of the positive and negative symptoms and cognitive dysfunction of schizophrenia

(2009) T.A. Hauser et al.   BIOCHEMICAL PHARMACOLOGY

Differential Regulation of α7 Nicotinic Receptor Gene (CHRNA7) Expression in Schizophrenic Smokers

(2009) Sharon Mexal et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

Schizophrenia, “just the facts” 4. Clinical features and conceptualization

(2009) Rajiv Tandon et al.   SCHIZOPHRENIA RESEARCH

Initial Phase 2 Trial of a Nicotinic Agonist in Schizophrenia

(2008) Robert Freedman et al.   AMERICAN JOURNAL OF PSYCHIATRY

The MATRICS Consensus Cognitive Battery, Part 2: Co-Norming and Standardization

(2008) Robert S. Kern et al.   AMERICAN JOURNAL OF PSYCHIATRY

The MATRICS Consensus Cognitive Battery, Part 1: Test Selection, Reliability, and Validity

(2008) Keith H. Nuechterlein et al.   AMERICAN JOURNAL OF PSYCHIATRY

Galantamine for the Treatment of Cognitive Impairments in People With Schizophrenia

(2007) Robert W. Buchanan et al.   AMERICAN JOURNAL OF PSYCHIATRY